Haight, Barbara R
Learned, Susan M
Laffont, Celine M
Fudala, Paul J
Zhao, Yue
Garofalo, Amanda S
Greenwald, Mark K
Nadipelli, Vijay R
Ling, Walter
Heidbreder, Christian
Andersen, James L.
Bailey, Genie L.
Bartley, Scott Robert
Biunno, Michael J.
Boyett, Brent
Carr, Jesse M.
Cifuentes, Eduardo
Duarte-Sckell, Sandra Daniela
Dueno, Otto R.
Harrison, Boyde J.
Hassman, David R.
Hoffman, Kent Steven
Isacesu, Valentin
Ishaque, Saleem
Kakar, Rishi
Kampman, Kyle
Knapp, Richard D.
Konis, George
Kunovac, Jelena
Kwentus, Joseph A.
Levinson, Lawrence S.
Malhotra, Shishuka
Mehra, Vishaal
Mofsen, Ricky Stuart
Peyton, Marvin Lane
Pujari, Gita G.
Ranjan, Rakesh
Rutrick, Daniel
Seal, Gregory
Segal, Scott Daniel
Shiwach, Rajinder
Thomas, Haydn Mikel
Ventre, Peter Paul
Vijapura, Amit K.
Walling, David P.
Wiest, Katharina L.
This article is maintained by: Elsevier
Article Title: Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(18)32259-1
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(18)32428-0
Content Type: article
Copyright: © 2019 Elsevier Ltd. All rights reserved.